This commentary is part of a collection of articles that describe various aspects of incorporating content into the medical school curriculum to enhance the preparation of today’s medical students to meet the needs of people with disabilities. The authors briefly describe the scope of the problem and define the population of people with disabilities that constitutes the focus of the work described in the other articles in this collection.
Our Work
Journal Article
September 01, 2011
Journal article on the benefits of teaching medical students about working with patients with disabilities.
Technical Report
August 12, 2011
Pipeline PredictorRx™ evaluates new drugs, expected to have a significant clinical or financial impact.
Journal Article
August 05, 2011
The changes enacted by the Patient Protection and Affordable Care Act are designed to substantially increase health insurance coverage. The authors analyze health care reform to assess the potential for increased insurance coverage among persons with disabilities.
Journal Article
July 01, 2011
This study seeks information about the prevalence, epidemiology, and management of self-injurious behavior by inmates in U.S. prison systems.
Blog
July 01, 2011
An article in the Ryan White Voices Caregiver Stories series that describes the experience as a nurse pratictioner treating patients when the AIDS epidemic began in the early 1980s.
Technical Report
June 20, 2011
This report provides a snapshot of the innovative programs we have initiated and conducted on behalf of the Commonwealth of Massachusetts. Our team has generated revenue and achieved cost avoidance totaling $26 billion over a 15-year period. Much can be accomplished when the family of state agencies in Massachusetts collaborate and combine their strengths to better serve the public.
Technical Report
June 15, 2011
Pipeline Trends features concise, impartial data on drugs in development and their potential place in therapy. This issue includes updates on aclidinium bromide, aflibercept, dimethyl fumarate, elvitegravir, and other new drugs.
